|Day Low/High||41.66 / 42.02|
|52 Wk Low/High||28.19 / 42.09|
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, is reinforcing its commitment to the United Nations Sustainable Development Goals by launching a series of global programs that enable and...
- Designed to support earlier, easier and more confident diagnosis to enhance the patient experience
Philips' Trilogy offer multiple ventilation modes, real time data sharing capabilities and a long battery life that allows patients to have a near normal quality of life.
- Highlights patient-centric interventional peripheral vascular solutions for diagnosis, image-guided therapy and connected care
With availability for primary diagnostic use in North America, Europe and Asia, Philips IntelliSite Pathology Solution is helping labs worldwide to improve the efficiency and quality of cancer diagnostics
Research from Philips and the George Washington University School of Medicine & Health Sciences reveals unsustainable emergency department (ED) use in seven developed nations
Lakeland Health to integrate Philips IntelliVue Guardian automated Early Warning Scoring (EWS) Solution for early intervention
Consolidation, improving equity prices and sufficient firepower for deals continue to fuel med tech M&A, according to EY's Jeff Greene.
Philips said it doesn't know if Third Point has taken stake
Combination of innovation and expertise better enables health systems to meet regulatory compliance while managing radiation doses for patients
92 percent of the U.S. COPD patients studied did not receive PAP therapy despite possible benefits
U.S. stock futures point to a mixed start for Wall Street on Wednesday, June 28.
Royal Philips said Wednesday that it will buy medical devices maker Spectranetics Corporation in a deal that carries an enterprise value of around €1.9 billion.
Enhanced applications for neurology, cardiology and oncology help clinicians analyze and compare medical images, evaluate treatment options, and track therapy response over time
Showcases continued commitment to creating innovative solutions that enhance and simplify the clinical decision making path, from diagnosis to treatment, to drive more personalized care
Former Olympic gold medalist, David Plummer, joins Philips to discuss his journey with sleep apnea treatment
- Debuts IntelliSpace Oncology, an integrated oncology informatics solution enabling data-driven decision making and proactive patient involvement across care teams
- New "turnkey" approach to precision medicine seeks to deliver Intermountain's best practices into a streamlined service to be integrated at the point of care
- Agreement aims to enable precision diagnostics for pancreatic cancer by developing new methods* to resolve single-cell level differences within and between tumors
Study showed use of home non-invasive ventilation in conjunction with home oxygen therapy delayed hospital readmissions for patients with advanced disease
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.